BrainsWay announced that the Israel Ministry of Defense’s Rehabilitation Department has granted approval for the reimbursement of Deep Transcranial Magnetic Stimulation system therapy for qualifying patients with post-traumatic stress disorder, PTSD, at Israeli public hospitals. BrainsWay will continue its work toward expanding the available reimbursement for PTSD within the country, with the goal of potentially including more Israeli medical centers, as well as adding private clinic settings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BWAY:
- Israel Ministry of Defense Clears BrainsWay Deep TMS™ for PTSD Reimbursement at Israeli Hospitals
- BrainsWay Welcomes New Chief Medical Officer
- Brainsway appoints Bermudes as CMO
- BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
- Brainsway price target raised to $12.60 from $12 at Ladenburg